Brief: Catalyst Pharmaceuticals Q1 Revenue USD 141.4 Million Vs. IBES Estimate USD 131.5 Million
07/05/2025 21:15
May 07 (Reuters) - Catalyst Pharmaceuticals Q1 adjusted net income USD 86.6 million vs. IBES estimate USD 44.1 million. Q1 operating income USD 63.4 million vs. IBES estimate USD 53.9 million Q1 net income USD 56.7 million outlook FY revenue USD 545-565 million